Showing results (751-760 of 884) with videos related to
Sort By:
Pageof 89
Clinical Biochemistry|December 29, 2009
Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacinIsabelle K Delattre, Flora T Musuamba, Roger K Verbeeck, et al.Journal of Critical Care|September 11, 2016
What is an intensive care unit? A report of the task force of the World Federation of Societies of Intensive and Critical Care MedicineJohn C Marshall, Laura Bosco, Neill K Adhikari, et al.Computers in Biology and Medicine|August 18, 2020
Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trialHoyt Burdick, Carson Lam, Samson Mataraso, et al.Intensive Care Medicine|April 5, 2017
The intensive care medicine research agenda in nutrition and metabolismYaseen M Arabi, Michael P Casaer, Marianne Chapman, et al.Critical Care (London, England)|September 3, 2005
Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studiesJean-Louis Vincent, Simon Nadel, Demetrios J Kutsogiannis, et al.Critical Care (London, England)|September 2, 2020
The importance of airway and lung microbiome in the critically illIgnacio Martin-Loeches, Robert Dickson, Antoni Torres, et al.Critical Care (London, England)|November 18, 2022
Effect of an enteral amino acid blend on muscle and gut functionality in critically ill patients: a proof-of-concept randomized controlled trialNicholas Heming, Robert Carlier, Helene Prigent, et al.Intensive Care Medicine|April 15, 2016
Comfort and patient-centred care without excessive sedation: the eCASH conceptJean-Louis Vincent, Yahya Shehabi, Timothy S Walsh, et al.Scientific Reports|August 11, 2021
Brain tissue oxygenation guided therapy and outcome in non-traumatic subarachnoid hemorrhageElisa Gouvea Bogossian, Daniela Diaferia, Narcisse Ndieugnou Djangang, et al.Critical Care Medicine|June 22, 2010
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsisTodd W Rice, Arthur P Wheeler, Gordon R Bernard, et al.Pageof 89